Emily M. Leproust, Chief Executive Officer at Twist Bioscience Corp (TWST), sold 46,391 shares at $200.00 ($8.8M) on 2026-10-01, disclosed to the SEC on 2026-10-05.
Scheduled sale ($8.8M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $200.00 | 655 | $131K | 1.5% |
| 2 | $188.88 | 45,736 | $8.6M | 98.5% |
| Total | $189.04 avg | 46,391 | $8.8M | 100% |
| Filing → |
| TWST | SELL | 2026-09-23 | $279K | — | Filing → |
| TWST | SELL | 2026-09-21 | $56.3M | — | Filing → |
| TWST | SELL | 2026-09-10 | $282K | — | Filing → |